These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5056625)

  • 1. LDH activity of red cells in chronic renal failure.
    Melissinos K; Drivas G; Vlassopoulos K
    Clin Chim Acta; 1972 Aug; 40(1):165-9. PubMed ID: 5056625
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of the activity of erythrocyte acid phosphatase in chronic renal failure.
    Melissinos K; Vlassopoulos K; Drivas G; Kourounis G
    Clin Chim Acta; 1973 Jan; 43(2):195-9. PubMed ID: 4265808
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of haemodialysate and its peptide fractions on lactate dehydrogenase activity in erythrocytes from healthy subjects and patients with end-stage renal disease.
    Smoleński O; Tabarowski Z; Miszta H; Dabrowski Z
    Int Urol Nephrol; 1992; 24(6):673-8. PubMed ID: 1289279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The catalase activity of erythrocytes in chronic renal failure.
    Melissinos KG; Vlassopoulos K; Drivas G; Tsoukantas A
    Clin Chim Acta; 1976 Jan; 66(2):267-8. PubMed ID: 1245073
    [No Abstract]   [Full Text] [Related]  

  • 5. Transketolase activity in red blood cells in chronic uremia.
    Kopple JD; Dirige OV; Jacob M; Wang M; Swendseid ME
    Trans Am Soc Artif Intern Organs; 1972; 18(0):250-6, 266. PubMed ID: 4610963
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythroid-cell enzyme activity in chronic renal failure.
    Stuart J; Skowron PN; Kramer JJ; Nelstrop GA
    Lancet; 1968 Aug; 2(7563):297-9. PubMed ID: 4173729
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma 3-deoxyglucosone elevation in chronic renal failure is associated with increased aldose reductase in erythrocytes.
    Hasuike Y; Nakanishi T; Otaki Y; Nanami M; Tanimoto T; Taniguchi N; Takamitsu Y
    Am J Kidney Dis; 2002 Sep; 40(3):464-71. PubMed ID: 12200796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of uremic middle molecules on the activity of erythrocyte lactate dehydrogenase (LDH)].
    Severini G; Malaguti-Aliberti L
    Ann Ist Super Sanita; 1985; 21(3):357-61. PubMed ID: 3834809
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythrocyte glucose-6-phosphate dehydrogenase in chronic renal failure and after renal transplantation.
    Milman N
    Scand J Haematol; 1980 Apr; 24(4):307-14. PubMed ID: 6997987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carbohydrate metabolism of erythrocytes in chronic terminal renal failure].
    Kopczyński Z; Chmiel J; Baczyk K
    Pol Arch Med Wewn; 1982 Apr; 67(4):169-76. PubMed ID: 7134023
    [No Abstract]   [Full Text] [Related]  

  • 11. [Total activity and profile of lactic dehydrogenase isoenzymes in the serum of patients with chronic renal failure].
    Markiewicz K; Kubasiewicz-Ujma B; Lutz W
    Pol Tyg Lek; 1972 Jan; 27(5):172-4. PubMed ID: 5010761
    [No Abstract]   [Full Text] [Related]  

  • 12. [Erythrocyte enzymes in chronic kidney failure].
    Khlebarova M; Dishlianova B; Belovezhdov N; Robeva R; Savova R
    Vutr Boles; 1985; 24(1):120-7. PubMed ID: 4024601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolidase and prolinase activities in the erythrocytes of patients with chronic uremia.
    Gejyo F; Kishore BK; Arakawa M
    Nephron; 1983; 35(1):58-61. PubMed ID: 6888626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and erythrocyte glutathione reductase activity in chronic renal failure.
    Melissinos KG; Delidou AZ; Varsou AG; Begietti SS; Drivas GJ
    Nephron; 1981; 28(2):76-9. PubMed ID: 7290275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of hemodialysate and its peptide fractions on stromal cells and heme synthesis in bone marrow culture and the activity of selected enzymes and GSH level of human erythrocytes. I. Effect on LDH activity in healthy persons and patients with terminal renal failure].
    Smoleński O
    Przegl Lek; 1989; 46(10):723-7. PubMed ID: 2594990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasmatic and erythrocytic angiotensinase activity in subjects with chronic uremia before and after treatment with dialysis].
    Ripa R; Degli Atti B; Cavagna R
    Minerva Med; 1970 Mar; 61(26):1307-13. PubMed ID: 4314603
    [No Abstract]   [Full Text] [Related]  

  • 17. Adeninephosphoribosyltransferase (APRT)-activity in patients with nephrolithiasis or renal failure.
    Banholzer P; Gröbner W; Löffler W; Reiter S; Zöllner N
    Adv Exp Med Biol; 1984; 165 Pt A():27-31. PubMed ID: 6720389
    [No Abstract]   [Full Text] [Related]  

  • 18. [Metabolic processes in the erythrocytes in disordered kidney function].
    Shepotinovskiĭ VI
    Urol Nefrol (Mosk); 1983; (3):62-6. PubMed ID: 6224339
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of haemodialysate and its peptide fractions on acetylcholinesterase activity in erythrocytes from healthy subjects and patients with terminal renal failure.
    Smoleński O; Tabarowski Z; Miszta H; Dabrowski Z
    Int Urol Nephrol; 1993; 25(5):503-8. PubMed ID: 8270380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of thrombocyte adenylate cyclase activity in terminal renal failure.
    Lübbecke F; Matthias FR; Wizemann V
    Thromb Haemost; 1991 Nov; 66(5):623-4. PubMed ID: 1820781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.